Mangel W F, Singer P T, Cyr D M, Umland T C, Toledo D L, Stroud R M, Pflugrath J W, Sweet R M
Biology Department, Brookhaven National Laboratory, Upton, New York 11973.
Biochemistry. 1990 Sep 11;29(36):8351-7. doi: 10.1021/bi00488a022.
The crystal and molecular structure of trypsin at a transiently stable intermediate step during catalysis has been determined by X-ray diffraction methods. Bovine trypsin cleaved the substrate p-nitrophenyl p-guanidinobenzoate during crystallization under conditions in which the acyl-enzyme intermediate, (guanidinobenzoyl)trypsin, was stable. Orthorhombic crystals formed in space group P2(1)2(1)2(1), with a = 63.74, b = 63.54, and c = 68.93 A. This is a crystal form of bovine trypsin for which a molecular structure has not been reported. Diffraction data were measured with a FAST (Enraf Nonius) diffractometer. The structure was refined to a crystallographic residual of R = 0.16 for data in the resolution range 7.0-2.0 A. The refined model of (guanidinobenzoyl)trypsin provides insight into the structural basis for its slow rate of deacylation, which in solution at 25 degrees C and pH 7.4 exhibits a t1/2 of 12 h. In addition to the rotation of the Ser-195 hydroxyl away from His-157, C beta of Ser-195 moves 0.7 A toward Asp-189 at the bottom of the active site, with respect to the native structure. This allows formation of energetically favorable H bonds and an ion pair between the carboxylate of Asp-189 and the guanidino group of the substrate. This movement is dictated by the rigidity of the aromatic ring in guanidinobenzoate--model-building indicates that this should not occur when arginine, with its more flexible aliphatic backbone, forms the ester bond with Ser-195. As a consequence, highly ordered water molecules in the active site are no longer close enough to the scissile ester bond to serve as potential nucleophiles for hydrolysis.(ABSTRACT TRUNCATED AT 250 WORDS)
通过X射线衍射方法测定了催化过程中处于瞬时稳定中间步骤的胰蛋白酶的晶体和分子结构。在结晶过程中,牛胰蛋白酶在使酰基酶中间体(胍基苯甲酰基)胰蛋白酶稳定的条件下切割底物对硝基苯基对胍基苯甲酸酯。在空间群P2(1)2(1)2(1)中形成正交晶体,a = 63.74,b = 63.54,c = 68.93 Å。这是一种尚未报道过分子结构的牛胰蛋白酶晶体形式。用FAST(恩拉夫·诺尼乌斯)衍射仪测量衍射数据。对于7.0 - 2.0 Å分辨率范围内的数据,结构精修至晶体学残余因子R = 0.16。(胍基苯甲酰基)胰蛋白酶的精修模型揭示了其脱酰化速率缓慢的结构基础,在25℃和pH 7.4的溶液中,其半衰期为12小时。除了Ser - 195羟基远离His - 157旋转外,相对于天然结构,Ser - 195的Cβ向活性位点底部的Asp - 189移动0.7 Å。这使得在Asp - 189的羧酸盐和底物的胍基之间形成能量上有利的氢键和离子对。这种移动由胍基苯甲酸中芳香环的刚性决定——模型构建表明,当具有更灵活脂肪族主链的精氨酸与Ser - 195形成酯键时,这种情况不应发生。因此,活性位点中高度有序的水分子不再与可裂解酯键足够接近,无法作为水解的潜在亲核试剂。(摘要截短于250字)